- Jul 2018
-
europepmc.org europepmc.org
-
On 2016 Dec 08, NephJC - Nephrology Journal Club commented:
This commentary on CKD staging and Precision Medicine was discussed on December 6th and 7th in the open online nephrology journal club, #NephJC, on twitter. Introductory comments written by Tom Oates and Kevin Fowler are available at the NephJC website here and here. The journal also kindly made the commentary free to access for this month. The discussion was quite detailed, with over 100 participants, including nephrologists, fellows and patients as well as author Jonathan Himmelfarb. The highlights of the tweetchat were:
The authors have written a richly referenced, thoughtful and though-provoking commentary, which is a must-read for anyone interested in gaining a perspective in this area.
The advent of eGFR reporting and CKD staging have resulted in many advances, including improved recognition and diagnosis, planning therapy, epidemiological estimates and public messaging. Nonetheless, the categorical staging system is not perfect (groups together diverse diseases) though opinion was sharply divided on the issue of CKD in the elderly being a true phenomenon versus an ageing effect.
The section on precision medicine in kidney disease was also quite nuanced, with a lot of optimism and ideas discussed, such as new trial designs and personalized care.
Transcripts of the tweetchats, and curated versions as storify are available from the NephJC website.
Interested individuals can track and join in the conversation by following @NephJC or #NephJC on twitter, liking @NephJC on facebook, signing up for the mailing list, or just visit the webpage at NephJC.com.
This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.
-
- Feb 2018
-
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
-
On 2016 Dec 08, NephJC - Nephrology Journal Club commented:
This commentary on CKD staging and Precision Medicine was discussed on December 6th and 7th in the open online nephrology journal club, #NephJC, on twitter. Introductory comments written by Tom Oates and Kevin Fowler are available at the NephJC website here and here. The journal also kindly made the commentary free to access for this month. The discussion was quite detailed, with over 100 participants, including nephrologists, fellows and patients as well as author Jonathan Himmelfarb. The highlights of the tweetchat were:
The authors have written a richly referenced, thoughtful and though-provoking commentary, which is a must-read for anyone interested in gaining a perspective in this area.
The advent of eGFR reporting and CKD staging have resulted in many advances, including improved recognition and diagnosis, planning therapy, epidemiological estimates and public messaging. Nonetheless, the categorical staging system is not perfect (groups together diverse diseases) though opinion was sharply divided on the issue of CKD in the elderly being a true phenomenon versus an ageing effect.
The section on precision medicine in kidney disease was also quite nuanced, with a lot of optimism and ideas discussed, such as new trial designs and personalized care.
Transcripts of the tweetchats, and curated versions as storify are available from the NephJC website.
Interested individuals can track and join in the conversation by following @NephJC or #NephJC on twitter, liking @NephJC on facebook, signing up for the mailing list, or just visit the webpage at NephJC.com.
This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.
-